SA

Syed Azeem Uddin

Active Director Director DIN 07450115
DIN 07450115 First appointment Oct 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value •••• Premium profile

About Syed Azeem Uddin

Data last updated:

Syed Azeem Uddin is a Director at Elmus Pharmaceuticals Private Limited (since 2018). The company operates in Chemicals. Elmus Pharmaceuticals Private Limited reported revenue of ₹2.2 Lakh (FY 2019).

DIN 07450115
Primary Designation Director
Industry Chemicals
First Appointment 30 Oct 2018
Oldest Company Age 10 yrs
Largest company Elmus Pharmaceuticals Private Limited · ₹2.2 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Oct 20182016₹2.2 Lakh (FY 2019)Active

Board colleagues of Syed Azeem Uddin

Directorship timeline

Open interactive timeline →
Elmus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Syed Azeem Uddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syed Azeem Uddin

Syed Azeem Uddin currently holds 1 directorship: Elmus Pharmaceuticals Private Limited (Director, since 30 Oct 2018, revenue ₹2.2 Lakh (FY 2019)).

Syed Azeem Uddin was first appointed on 30 Oct 2018 as Director at Elmus Pharmaceuticals Private Limited.

The current boards of Syed Azeem Uddin's companies include Mohammed Ibrahim Ahmed (Elmus Pharmaceuticals Private Limited), Mohammed Mohi Uddin Ahmed (Elmus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available